Back to Search Start Over

Continuous Anticoagulation and Cold Snare Polypectomy Versus Heparin Bridging and Hot Snare Polypectomy in Patients on Anticoagulants With Subcentimeter Polyps: A Randomized Controlled Trial.

Authors :
Takeuchi Y
Mabe K
Shimodate Y
Yoshii S
Yamada S
Iwatate M
Kawamura T
Hotta K
Nagaike K
Ikezawa N
Yamasaki T
Komeda Y
Asai S
Abe Y
Akamatsu T
Sakakibara Y
Ikehara H
Kinjo Y
Ohta T
Kitamura Y
Shono T
Inoue T
Ohda Y
Kobayashi N
Tanuma T
Sato R
Sakamoto T
Harada N
Chino A
Ishikawa H
Nojima M
Uraoka T
Source :
Annals of internal medicine [Ann Intern Med] 2019 Aug 20; Vol. 171 (4), pp. 229-237. Date of Electronic Publication: 2019 Jul 16.
Publication Year :
2019

Abstract

Background: Management of anticoagulants for patients undergoing polypectomy is still controversial. Cold snare polypectomy (CSP) is reported to cause less bleeding than hot snare polypectomy (HSP).<br />Objective: To compare outcomes between continuous administration of anticoagulants (CA) with CSP (CA+CSP) and periprocedural heparin bridging (HB) with HSP (HB+HSP) for subcentimeter colorectal polyps.<br />Design: Multicenter, parallel, noninferiority randomized controlled trial. (University Hospital Medical Information Network Clinical Trials Registry: UMIN000019355).<br />Setting: 30 Japanese institutions.<br />Patients: Patients receiving anticoagulant therapy (warfarin or direct oral anticoagulants) who had at least 1 nonpedunculated subcentimeter colorectal polyp.<br />Intervention: Patients were randomly assigned to undergo HB+HSP or CA+CSP and followed up 28 days after polypectomy.<br />Measurements: The primary end point was incidence of polypectomy-related major bleeding (based on the incidence of poorly controlled intraprocedural bleeding or postpolypectomy bleeding requiring endoscopic hemostasis). The prespecified inferiority margin was -5% (CA+CSP vs. HB+HSP).<br />Results: A total of 184 patients were enrolled: 90 in the HB+HSP group, 92 in the CA+CSP group, and 2 who declined to participate after enrollment. The incidence of polypectomy-related major bleeding in the HB+HSP and CA+CSP groups was 12.0% (95% CI, 5.0% to 19.1%) and 4.7% (CI, 0.2% to 9.2%), respectively. The intergroup difference for the primary end point was +7.3% (CI, -1.0% to 15.7%), with a 0.4% lower limit of 2-sided 90% CI, demonstrating the noninferiority of CA+CSP. The mean procedure time for each polyp and the hospitalization period were longer in the HB+HSP than in the CA+CSP group.<br />Limitation: An open-label trial assessing 2 factors (anticoagulation approach and polypectomy procedure type) simultaneously.<br />Conclusion: Patients having CA+CSP for subcentimeter colorectal polyps who were receiving oral anticoagulants did not have an increased incidence of polypectomy-related major bleeding, and procedure time and hospitalization were shorter than in those having HB+HSP.<br />Primary Funding Source: Japanese Gastroenterological Association.

Details

Language :
English
ISSN :
1539-3704
Volume :
171
Issue :
4
Database :
MEDLINE
Journal :
Annals of internal medicine
Publication Type :
Academic Journal
Accession number :
31307055
Full Text :
https://doi.org/10.7326/M19-0026